Sequential systemic treatment in advanced hepatocellular carcinoma is able to prolong median survival to more than three years

J von Felden, K Karkmann, H Ittrich, I Gil-Ibanez, T Fründt, J Krause,AW Lohse, H Wege, K Schulze

Zeitschrift für Gastroenterologie74. Jahrestagung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten mit Sektion Endoskopie – 13. Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie gemeinsam mit den Arbeitsgemeinschaften der DGAV（2019）

引用 0|浏览1

暂无评分

摘要

The number of efficacious systemic agents for advanced hepatocellular carcinoma (HCC) has rapidly increased over the past two years. However, guidance for optimal sequential systemic treatment in patients with advanced disease and experience with outcome and safety profiles are lacking. Thus, we aimed to assess efficacy and tolerability of sequential systemic therapy of HCC.

查看译文

关键词

advanced hepatocellular carcinoma,hepatocellular carcinoma,sequential systemic treatment,median survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要